超声引导热消融与手术治疗T1N0M0甲状腺乳头状癌:系统评价与Meta分析
该系统评价与Meta分析纳入16项研究共5045例T1N0M0甲状腺乳头状癌患者,比较超声引导热消融与手术的疗效与安全性。结果显示两组在复发、淋巴结转移、暂时性声嘶、血肿和感染方面无显著差异,热消融显著降低永久性声嘶、甲状旁腺功能减退、吞咽困难、手术时间、住院时间、费用、估计失血量和手术切口(均P<.05)。作者结论认为超声引导热消融是T1a和T1b期T1N0M0甲状腺乳头状癌安全有效的替代手术方案。
要点
- 热消融与手术在复发(OR=1.464)、淋巴结转移(OR=0.817)等方面无显著差异。
- 热消融显著降低永久性声嘶、甲状旁腺功能减退、吞咽困难等并发症(均P<.05)。
- 亚组分析显示T1a/T1b、微波/射频及随访时间亚组主要结局相似。
核心结论
- 超声引导热消融是T1a和T1b期T1N0M0甲状腺乳头状癌安全有效的替代手术方案,预后结局相当,并发症更少、费用更低、恢复更快。
研究设计与样本
- 系统评价与Meta分析,纳入16项比较热消融与手术的研究,共5045例T1N0M0甲状腺乳头状癌患者,检索截至2024年10月23日,计算标准化均数差和比值比(OR)及95%置信区间(CI)。
诊断标准与关键数值
- 复发:OR=1.464(95%CI 0.881, 2.433;P=.141),无显著差异。
- 淋巴结转移:OR=0.817(95%CI 0.492, 1.356;P=.434),无显著差异。
- 暂时性声嘶:OR=0.700(95%CI 0.339, 1.445;P=.334),无显著差异。
- 血肿:OR=0.528(95%CI 0.187, 1.492;P=.228),无显著差异。
- 感染:OR=0.368(95%CI 0.060, 2.268;P=.281),无显著差异。
临床应用与阅片要点
- 热消融与手术在复发、淋巴结转移、暂时性声嘶、血肿和感染方面无显著差异。
- 热消融显著降低永久性声嘶、甲状旁腺功能减退、吞咽困难、手术时间、住院时间、费用、估计失血量和手术切口(均P<.05)。
- 亚组分析显示T1a/T1b分期、微波/射频类型及短期/长期随访亚组主要结局相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Ultrasound-guided thermal ablation (TA) offers a minimally invasive alternative to surgery for T1N0M0 papillary thyroid carcinoma (PTC), but its efficacy and safety remain controversial. This meta-analysis aimed to evaluate and compare the outcomes of TA and surgery in treating T1N0M0 PTC, encompassing both T1a and T1b stages.
MATERIALS AND METHODS: We conducted a systematic review and meta-analysis including studies comparing TA and surgery for T1N0M0 PTC up to October 23, 2024. Standardized mean differences and odds ratios (OR) with 95% confidence intervals (CI) were calculated for primary and secondary outcomes.
RESULTS: Sixteen studies with a total of 5045 patients were analyzed. No significant differences were observed in recurrence (OR=1.464; 95% CI=0.881, 2.433; P=.141), lymph node metastasis (OR=0.817; 95% CI=0.492, 1.356; P=.434), transient hoarseness (OR=0.700; 95% CI=0.339, 1.445; P=.334), hematoma (OR=0.528; 95% CI=0.187, 1.492; P=.228), and infection (OR=0.368; 95% CI=0.060, 2.268; P=.281). Notably, TA significantly reduced permanent hoarseness, hypoparathyroidism, dysphagia, procedure time, hospitalization, cost, estimated blood loss, and surgical incision (all P<.05). The subgroup analyses demonstrated similar primary outcomes within each subgroup, including tumor stage (T1a/T1b), type of TA (microwave/radiofrequency), and follow-up time (short-term/long-term).
CONCLUSION: Ultrasound-guided TA is a safe and effective alternative to surgery for both T1a and T1b stages of T1N0M0 PTC, offering comparable prognostic outcomes with fewer complications, lower costs, and faster recovery.
引用
- Chen Y, Li J, Zhao S, et al. Ultrasound-Guided Thermal Ablation vs Surgery in T1N0M0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40113470. doi:10.1016/j.acra.2025.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。